Neuroligin-Neurexin Interaction

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 16: Line 16:
====Mutations Leading To Neurodevelopmental Disorders====
====Mutations Leading To Neurodevelopmental Disorders====
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Several <scene name='Neuroligin-Neurexin_Interaction/Mutation_dimer/3'>point mutations</scene> (R437C (451 in NLGN 3), G99S, K378R, & V403M) within NLGN have been positively linked with Autism Spectrum Disorders. Although these mutations are remote from the NLGN-NRXN interface, conclusions can be drawn as to their impact on the function of NLGN. <scene name='Neuroligin-Neurexin_Interaction/Mutation_437/1'>Arg437Cys</scene>, a mutation shown to result in “savant” like attributes in mice, is believed to increase retention of NLGN in the endoplasmic reticulum preventing correct positioning at the cell surface. It could also disrupt a <scene name='Neuroligin-Neurexin_Interaction/Mutation_437_network/1'>dense network of charged residues</scene> (Asp 388, Asp 486, Glu 434, and Lys 338) through Trp 484, which are believed to be important for processing events. <scene name='Neuroligin-Neurexin_Interaction/Mutation_403/1'>Val403Met</scene> is believed to affect correct folding of the C-terminal domain of NLGN and prevent formation of the functional dimer. The <scene name='Neuroligin-Neurexin_Interaction/Mutation_378/1'>Lys378Arg mutation</scene> which interacts with the <scene name='Neuroligin-Neurexin_Interaction/Mutation_378_interaction/2'>Cys-loop Asp 122</scene> through Van der Waals contacts could disrupt the Cys-loop reducing NLGN structural integrity. These mutations do not entirely disrupt NLGNs interaction with NRXN, but do impact NLGN in the subtle ways from which [[Neurodevelopmental Disorders|autism]] likely arises.<ref name="Fabrichny"/>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Several <scene name='Neuroligin-Neurexin_Interaction/Mutation_dimer/3'>point mutations</scene> (R437C (451 in NLGN 3), G99S, K378R, & V403M) within NLGN have been positively linked with Autism Spectrum Disorders. Although these mutations are remote from the NLGN-NRXN interface, conclusions can be drawn as to their impact on the function of NLGN. <scene name='Neuroligin-Neurexin_Interaction/Mutation_437/1'>Arg437Cys</scene>, a mutation shown to result in “savant” like attributes in mice, is believed to increase retention of NLGN in the endoplasmic reticulum preventing correct positioning at the cell surface. It could also disrupt a <scene name='Neuroligin-Neurexin_Interaction/Mutation_437_network/1'>dense network of charged residues</scene> (Asp 388, Asp 486, Glu 434, and Lys 338) through Trp 484, which are believed to be important for processing events. <scene name='Neuroligin-Neurexin_Interaction/Mutation_403/1'>Val403Met</scene> is believed to affect correct folding of the C-terminal domain of NLGN and prevent formation of the functional dimer. The <scene name='Neuroligin-Neurexin_Interaction/Mutation_378/1'>Lys378Arg mutation</scene> which interacts with the <scene name='Neuroligin-Neurexin_Interaction/Mutation_378_interaction/2'>Cys-loop Asp 122</scene> through Van der Waals contacts could disrupt the Cys-loop reducing NLGN structural integrity. These mutations do not entirely disrupt NLGNs interaction with NRXN, but do impact NLGN in the subtle ways from which [[Neurodevelopmental Disorders|autism]] likely arises.<ref name="Fabrichny"/>
 +
__NOTOC__
 +
__NOEDITSECTION__
</StructureSection>
</StructureSection>

Revision as of 04:18, 13 March 2011

Structure of Neurexin and Neuroligin, 2wqz

Drag the structure with the mouse to rotate

Additional Structures of Neuroligin and Neurexin

For additional Structures of Neuroligin, See: Neuroligin
For additional Structures of Neurexin, See: Neurexin

References

  1. 1.0 1.1 1.2 Chih B, Engelman H, Scheiffele P. Control of excitatory and inhibitory synapse formation by neuroligins. Science. 2005 Feb 25;307(5713):1324-8. Epub 2005 Jan 27. PMID:15681343 doi:10.1126/science.1107470
  2. 2.0 2.1 2.2 2.3 2.4 2.5 2.6 Sudhof TC. Neuroligins and neurexins link synaptic function to cognitive disease. Nature. 2008 Oct 16;455(7215):903-11. PMID:18923512 doi:10.1038/nature07456
  3. 3.0 3.1 3.2 Tabuchi K, Blundell J, Etherton MR, Hammer RE, Liu X, Powell CM, Sudhof TC. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science. 2007 Oct 5;318(5847):71-6. Epub 2007 Sep 6. PMID:17823315 doi:10.1126/science.1146221
  4. Jamain S, Radyushkin K, Hammerschmidt K, Granon S, Boretius S, Varoqueaux F, Ramanantsoa N, Gallego J, Ronnenberg A, Winter D, Frahm J, Fischer J, Bourgeron T, Ehrenreich H, Brose N. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1710-5. Epub 2008 Jan 28. PMID:18227507 doi:10.1073/pnas.0711555105
  5. 5.0 5.1 5.2 5.3 5.4 Fabrichny IP, Leone P, Sulzenbacher G, Comoletti D, Miller MT, Taylor P, Bourne Y, Marchot P. Structural analysis of the synaptic protein neuroligin and its beta-neurexin complex: determinants for folding and cell adhesion. Neuron. 2007 Dec 20;56(6):979-91. PMID:18093521 doi:10.1016/j.neuron.2007.11.013
  6. Rudenko G, Nguyen T, Chelliah Y, Sudhof TC, Deisenhofer J. The structure of the ligand-binding domain of neurexin Ibeta: regulation of LNS domain function by alternative splicing. Cell. 1999 Oct 1;99(1):93-101. PMID:10520997

Proteopedia Page Contributors and Editors (what is this?)

David Canner, Michal Harel

Personal tools